Related Experiment Video
Updated: Feb 10, 2026

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
Published on: October 12, 2018
Inhibition of Human Immunodeficiency Virus Type 1 Entry by a Keggin Polyoxometalate
Xiaoli Wang1, Jiao Wang2, Wenmei Zhang3
1College of Life Science and Bioengineering, Beijing University of Technology, Beijing 100124, China. wangxiaoli@bjut.edu.cn.
Abstract:
Here, we report the anti-human immunodeficiency virus (HIV) potency and underlying mechanisms of a Keggin polyoxometalate (PT-1, K₆HPTi₂W10O40). Our findings showed that PT-1 exhibited highly potent effects against a diverse group of HIV type 1 (HIV-1) strains and displayed low cytotoxicity and genotoxicity. The time-addition assay revealed that PT-1 acted at an early stage of infection, and these findings were supported by the observation that PT-1 had more potency against Env-pseudotyped virus than vesicular stomatitis virus glycoprotein (VSVG) pseudotyped virus. Surface plasmon resonance binding assays and flow cytometry analysis showed that PT-1 blocked the gp120 binding site in the CD4 receptor. Moreover, PT-1 bound directly to gp41 NHR (N36 peptide), thereby interrupting the core bundle formation of gp41. In conclusion, our data suggested that PT-1 may be developed as a new anti-HIV-1 agent through its effects on entry inhibition.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Feedback Inhibition
What are Viruses?
Enzyme Inhibition
Inhibition of Cdk Activity
Types of Genetic Transfer Between Organisms

